Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2014 Sep 16;7(6):863–871. doi: 10.1161/CIRCIMAGING.114.002411

Figure 3.

Figure 3

Bar chart comparing the prevalence of the 4 phenotypic abnormalities between controls, carriers bearing non-MYBPC3 mutations and carriers bearing the MYBPC3 mutation.

AMVL = anterior mitral valve leaflet; LVESViR = left ventricular end-systolic volume adjusted for age, body surface area and gender; FDMaxApical = maximal apical fractal dimension; MYBPC3 = myosin-binding protein C, cardiac type; NS = not significant.